Thursday, 5 March 2009

Maprotiline




In the US, Maprotiline (maprotiline systemic) is a member of the drug class tetracyclic antidepressants and is used to treat Depression and Panic Disorder.

US matches:

  • Maprotiline

  • Maprotiline Hydrochloride

  • Maprotiline HCl

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N06AA21

CAS registry number (Chemical Abstracts Service)

0010262-69-8

Chemical Formula

C20-H23-N

Molecular Weight

277

Therapeutic Category

Antidepressant, tetracyclic

Chemical Name

9,10-Ethanoanthracene-9(10H)-propanamine, N-methyl-

Foreign Names

  • Maprotilinum (Latin)
  • Maprotilin (German)
  • Maprotiline (French)
  • Maprotilina (Spanish)

Generic Names

  • Maprotilina (OS: DCIT)
  • Maprotiline (OS: DCF, BAN, USAN)
  • Maprotiline Hydrochloride (OS: BANM, JAN)
  • Ba 34276 (IS)
  • Maprotiline (chlorhydrate de) (PH: Ph. Eur. 6)
  • Maprotiline Hydrochloride (PH: BP 2010, JP XIV, USP 32, Ph. Eur. 6)
  • Maprotilinhydrochlorid (PH: Ph. Eur. 6)
  • Maprotilini hydrochloridum (PH: Ph. Eur. 6)
  • Maprotiline methanesulfonate (IS)

Brand Names

  • Ludiomil
    Novartis, Tunisia; Novartis, Tunisia


  • Mapromil
    Farmo Quimica, Chile


  • Maprotilin
    Zdravlje, Serbia


  • Siprotilin
    Sicomed, Romania


  • Cronmolin
    Takata Seiyaku, Japan


  • Epalon
    Remedica, Cyprus


  • Ladiomil
    Pliva, Bosnia & Herzegowina; Pliva, Croatia (Hrvatska); Pliva, Slovenia


  • Ludiomil
    AFT, New Zealand; Amdipharm, Sweden; CSP, France; Dolorgiet, Germany; Novartis, Austria; Novartis, Bangladesh; Novartis, Belgium; Novartis, Bulgaria; Novartis, Brazil; Novartis, Switzerland; Novartis, China; Novartis, Colombia; Novartis, Czech Republic; Novartis, Denmark; Novartis, Spain; Novartis, Ghana; Novartis, Greece; Novartis, Guyana; Novartis, Hungary; Novartis, Indonesia; Novartis, Iceland; Novartis, Italy; Novartis, Japan; Novartis, Kenya; Novartis, Luxembourg; Novartis, Libya; Novartis, Malta; Novartis, Malaysia; Novartis, Nigeria; Novartis, Oman; Novartis, Poland; Novartis, Portugal; Novartis, Romania; Novartis, Russian Federation; Novartis, Sudan; Novartis, Slovakia; Novartis, Thailand; Novartis, Turkey; Novartis, Taiwan; Novartis, Tanzania; Novartis, Venezuela; Novartis, Zimbabwe


  • Ludios
    Soho, Indonesia


  • Maprolu
    Hexal, Germany; Hexal, Luxembourg


  • Mapromil
    Kobayashi Kako, Japan


  • Maprotibene
    Merckle, Czech Republic


  • Maprotil
    Terra, Turkey


  • Maprotilin Holsten
    Holsten, Germany


  • Maprotilin Mylan
    Mylan, Sweden


  • Maprotilin
    Promedic, Romania


  • Maprotilina Ratiopharm
    Ratiopharm, Portugal


  • Maprotilin-CT
    CT Arzneimittel, Germany


  • Maprotiline HCl CF
    Centrafarm, Netherlands


  • Maprotiline HCl Merck
    Mylan, Netherlands


  • Maprotiline HCl PCH
    Pharmachemie, Netherlands


  • Maprotiline HCl ratiopharm
    ratiopharm, Netherlands


  • Maprotiline HCl Sandoz
    Sandoz, Netherlands


  • Maprotiline Hydrochloride
    Mylan, United States


  • Maprotilin-neuraxpharm
    Neuraxpharm, Germany


  • Maprotilin-ratiopharm
    Ratiopharm, Germany; Ratiopharm, Taiwan


  • Maprotilin-Teva
    Teva, Germany


  • Melodil
    Unipharm, Israel


  • Neuomil
    Kyowa Yakuhin, Japan


  • Novo-Maprotiline
    Novopharm, Canada


  • Sandepril
    Mersifarma, Indonesia


  • Tilsan
    Otto, Indonesia


  • Ladiomil
    Pliva, Croatia (Hrvatska)


  • Ludiomil
    Dolorgiet, Germany; Novartis, Austria; Novartis, Belgium; Novartis, Brazil; Novartis, Switzerland; Novartis, Guyana; Novartis, Luxembourg


  • Maprolu
    Hexal, Germany


  • Maprotilin-neuraxpharm
    Neuraxpharm, Germany

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment